Walking Pneumonia, the Beginning of Influenza Season, and Does Antiv…

MicrobeTV

D. Griffin, V. Racaniello

IDWeek 2024 Insights: To Mask or Not to Mask - Approaches to Source …

IDWeek 2024 Insights

E. Landon

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

Project 2025 vs. the Public's Health Part III: The NIH

MicrobeTV

P. Offit, V. Racaniello

CHEST 2024 Insights: Vaccination Challenges and Strategies for Viral…

CHEST Annual Meeting Insights

A. Kapoor

What's New with COVID in 2024?

Michigan Medicine

L. Washer

CHEST Insights 2024: Determining the Impact of COVID-19 Infection on…

CHEST Annual Meeting Insights

A. Arumairaj

Preventing Complications with Vaccines in Persons with Diabetes (PWD)

Allison Presnell

IDSA Guidelines for Using Anti-SARS-CoV-2 Monoclonal Antibody Therap…

MicrobeTV

D. Griffin, V. Racaniello

Monkeypox Declared a Public Health Emergency of International Concer…

MicrobeTV

D. Griffin, V. Racaniello

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

Mpox Circulation and New Vaccine Approval, Largest Outbreak of Whoop…

MicrobeTV

D. Griffin, V. Racaniello

IDWeek 2024 Insights: COVID-19 in Children - Navigating the Current …

IDWeek 2024 Insights

I. Anosike

Vaccination vs. Antiviral Therapy Against Mpox, Authorization and Ap…

MicrobeTV

D. Griffin, V. Racaniello

Unveiling the Facets of Post-Sepsis Syndrome: Physical and Neuropsyc…

Houston Methodist

D. Moran

September 2024 Public Health Infectious Disease Updates

California Medical Association

E. Pan

ACAAI 2024 Insights: The "Other" Respiratory Viruses and Asthma

ACAAI 2024 Insights

J. Kennedy

Recent ACIP Recommendations for RSV Vaccines for Patients Over 60, T…

MicrobeTV

D. Griffin, V. Racaniello

Fall COVID Booster Update, Effectiveness of Monoclonal Antibody Sotr…

MicrobeTV

D. Griffin, V. Racaniello

Mpox Circulation Updates, the Beginning of Influenza Season, and the…

MicrobeTV

D. Griffin, V. Racaniello